Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori (H. pylori) utilizes a sophisticated network of antioxidant and redox enzymes to survive the harsh, oxidative environment of the human stomach and the host's immune response. Key components of this system include superoxide dismutase (SodB), catalase (KatA), alkyl hydroperoxide reductase (AhpC), and the thioredoxin (Trx) system (Wang et al., 2006, Free Radical Biology and Medicine). These enzymes neutralize reactive oxygen species (ROS) such as superoxide radicals and hydrogen peroxide, which are generated by neutrophils and macrophages during the inflammatory response (Kusters et al., 2006, Clinical Microbiology Reviews). By maintaining redox homeostasis, these enzymes prevent oxidative damage to the bacterium's DNA, proteins, and lipids, thereby facilitating chronic colonization and contributing to the development of gastritis, peptic ulcers, and gastric adenocarcinoma (Smolka et al., 2012, Frontiers in Biology). Targeting these enzymes is a promising therapeutic strategy, as their inhibition increases the susceptibility of H. pylori to oxidative stress and host-mediated killing. Drugs like auranofin and ebselen have shown potential in inhibiting the thioredoxin reductase (TrxR) of H. pylori, which is essential for its survival and lacks a redundant backup system found in many other organisms (Lu et al., 2013, FASEB Journal).
Inhibition of key redox-regulating enzymes (e.g., thioredoxin reductase, catalase, superoxide dismutase) disrupts the bacterium's ability to neutralize host-derived reactive oxygen species, leading to oxidative stress, cellular damage, and bacterial death.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antioxidant and redox enzymes of Helicobacter pylori.